Apple v. AliveCor: Federal Circuit Appeal Voluntarily Dismissed in 38 Days
Apple filed a Federal Circuit appeal against AliveCor challenging the patentability of US10866619B1, covering sealed button biometric sensing systems in electronic devices. The parties agreed to dismiss the proceeding under Fed. R. App. P. 42(b) just 38 days after filing, with each side bearing its own costs.
A Swift Exit: Apple and AliveCor Agree to Drop Federal Circuit Fight
Apple, Inc. filed Case No. 25-1544 at the Court of Appeals for the Federal Circuit on 14 March 2025, appealing a patentability determination concerning US10866619B1 — a patent held by AliveCor, Inc. covering an electronic device having a sealed button biometric sensing system. The appeal was framed as an invalidity or cancellation action, suggesting the underlying proceeding involved a challenge to AliveCor’s patent before the USPTO or a lower tribunal.
The case closed on 21 April 2025 — just 38 days after filing — when the parties jointly agreed to dismiss the appeal under Federal Rule of Appellate Procedure 42(b). The Federal Circuit ordered the dismissal and specified that each side shall bear its own costs. Because the dismissal was voluntary and the public record does not specify whether it was with or without prejudice, the precise preclusive effect on future challenges remains unclear from the docket alone.
The speed of resolution — less than six weeks into what is typically a multi-month appellate process — suggests the parties reached an off-docket resolution, potentially a licensing arrangement or settlement of the broader dispute, though the public record is silent on any commercial terms. The mutual cost-bearing order is consistent with a negotiated exit rather than a capitulation by either side. Whether Apple retains the ability to re-challenge the patent in a separate proceeding depends on the undisclosed terms of the parties’ agreement.
Filing to Voluntary dismissal in 38 days
38 days — resolved well before full Federal Circuit briefing typically concludes
Voluntarily dismissed: what the agreed exit means for both parties
Fed. R. App. P. 42(b): consent dismissal at the appellate stage
Rule 42(b) allows a Federal Circuit appeal to be dismissed by stipulation of the parties or on motion of the appellant. Here, both Apple and AliveCor agreed to the dismissal. This procedural exit closes the appellate docket without any ruling on the merits of the patentability challenge — the Federal Circuit issued no opinion on whether the patent claims are valid or invalid.
No merits adjudicationWith or without prejudice? The public record is silent
A voluntary dismissal can be with prejudice — permanently barring re-litigation of the same claims — or without prejudice, leaving the door open. The docket records ‘Voluntary dismissal’ as the basis of termination but does not specify which applies here. Practitioners should treat the preclusive effect as uncertain unless the underlying stipulation or settlement agreement, which is not publicly available, clarifies the terms.
Preclusive effect unclearApple exits without a Federal Circuit ruling on validity
As appellant, Apple initiated this invalidity challenge. By agreeing to dismiss, Apple forfeits any appellate ruling in its favour on the patentability of US10866619B1 at this stage. This may signal that Apple resolved the underlying commercial dispute through negotiation, or that the strategic value of continuing the appeal diminished — though the public record does not confirm either conclusion.
No appellate win for challengerAliveCor’s patent survives this appellate challenge intact
With no merits ruling issued, US10866619B1 remains in force without any Federal Circuit cancellation or invalidity finding. AliveCor retains the patent as an enforceable asset covering sealed button biometric sensing systems. However, the absence of a definitive validity ruling means the patent has not been judicially confirmed as valid — a distinction that matters in any future enforcement action.
Patent survives; no validity rulingFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Apple, Inc. | Company | Apple, Inc. — consumer electronics company; appellant challenging validity of US10866619B1Search in Eureka ↗ |
| Defendant | AliveCor, Inc. | Company | AliveCor, Inc. — cardiac monitoring technology company; holder of US10866619B1Search in Eureka ↗ |
| Plaintiff counsel | Brian Rosenthal | Attorney | Counsel for Apple, Inc.Search in Eureka ↗ |
| Plaintiff counsel | Jaysen Chung | Attorney | Counsel for Apple, Inc.Search in Eureka ↗ |
| Plaintiff law firm | Gibson, Dunn & Crutcher, LLP | Law Firm | Representing Apple, Inc.Search in Eureka ↗ |
| Defendant counsel | Christopher Timothy Lawn Douglas | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Erin Beaton | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | J. Ravindra Fernando | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Katherine Rubschlager | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Kirk T. Bradley | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Matthew S. Stevens | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant counsel | Philip C. Ducker | Attorney | Counsel for AliveCor, Inc.Search in Eureka ↗ |
| Defendant law firm | Alston & Bird, LLP | Law Firm | Representing AliveCor, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | Court of Appeals for the Federal CircuitSearch in Eureka ↗ |
Official order — verbatim text
The Federal Circuit’s order is purely procedural: it records the parties’ agreement to dismiss under Fed. R. App. P. 42(b) and allocates costs equally. The court made no finding on patentability, validity, or claim scope of US10866619B1. For practitioners, this means the patent carries no appellate-level validity endorsement or invalidity finding — its enforceability rests solely on the USPTO grant. The mutual cost order, while not unusual in consented dismissals, suggests neither party extracted a concession significant enough to justify a cost award.
US10866619B1 — Sealed Button Biometric Sensing System
US10866619B1, filed under application number US15/627336, protects an electronic device incorporating a sealed button biometric sensing system. The patent sits at the intersection of hardware industrial design and biometric data capture — covering the integration of sensing capability within a physical button element while maintaining a sealed, likely water-resistant enclosure. This is directly relevant to wearable devices such as smartwatches and fitness trackers where button-integrated health monitoring is a core product feature.
AliveCor’s ownership of this patent positions the company as a significant IP stakeholder in the wearable cardiac and biometric monitoring market — a space dominated commercially by Apple Watch and competing platforms. The patent’s claim scope around sealed button biometric sensing is strategically valuable: it covers an interface paradigm used broadly in consumer wearables. Apple’s decision to challenge, then withdraw from, a Federal Circuit appeal over this patent suggests the asset carries meaningful commercial leverage in negotiations over wearable health technology.
Should your wearable product team run an FTO against US10866619B1?
Any R&D team or product company developing electronic devices — particularly smartwatches, fitness bands, medical wearables, or consumer health devices — that incorporate biometric sensors integrated within or adjacent to a physical button element should assess freedom-to-operate against US10866619B1. The patent survived a Federal Circuit challenge without an invalidity ruling, meaning it carries full enforcement presumption. This is especially urgent for companies preparing product launches or hardware refreshes in the wearable health category.
PatSnap Eureka’s FTO Search Agent can map US10866619B1’s claim scope against your product architecture, identify prosecution history estoppel, and surface prior art that may support design-around or invalidity arguments. Given the unresolved nature of the Apple–AliveCor dispute, monitoring this patent family for continuation applications or related assertions is equally important — Eureka’s patent family tracking and litigation alert tools are built precisely for this scenario.
Run a freedom-to-operate analysis on US10866619B1 to assess your product’s exposure
Run FTO in Eureka →Similar Federal Circuit Appeals in Wearable Biometric Patent Disputes
Cases involving biometric sensing patent validity at the Federal Circuit, including Apple and AliveCor’s broader dispute history in wearable health technology.
What this case signals for the wearable biometric IP landscape
A rapid voluntary dismissal at the Federal Circuit in a patentability dispute rarely means the underlying conflict has vanished.
Speed of resolution signals likely off-docket deal between Apple and AliveCor
Dismissing a Federal Circuit appeal within 38 days — before any briefs are typically due — is consistent with a concurrent licensing negotiation or broader settlement. Companies monitoring the Apple–AliveCor dispute in wearable cardiac monitoring and biometric sensing technology should watch for licensing announcements or product integration signals.
US10866619B1 remains legally unchallenged at appellate level — enforcement risk persists
No Federal Circuit ruling means no precedential invalidity finding. Any competitor operating in the sealed button biometric sensing space who relied on a potential Apple victory to clear IP risk must now independently assess their exposure to US10866619B1. An FTO analysis against this patent is advisable before product launch or expansion.
Apple v AliveCor — key questions answered
Apple filed a Federal Circuit appeal on 14 March 2025 challenging the patentability of AliveCor’s US10866619B1, covering a sealed button biometric sensing system. The parties agreed to voluntarily dismiss the appeal under Fed. R. App. P. 42(b) on 21 April 2025 — just 38 days later — with each side bearing its own costs. No merits ruling was issued.
US10866619B1 protects an electronic device having a sealed button biometric sensing system. Filed under application US15/627336 and held by AliveCor, the patent is relevant to wearable devices — such as smartwatches — where biometric sensors are integrated into sealed button interfaces. Its commercial significance lies in the overlap with Apple Watch and competing wearable health platforms.
No. A voluntary dismissal under Fed. R. App. P. 42(b) carries no merits adjudication. The Federal Circuit issued no opinion on the validity or invalidity of US10866619B1. The patent retains its USPTO-granted presumption of validity, but has not received appellate-level judicial confirmation. Future challengers are not necessarily barred by this dismissal, though the preclusive effect depends on undisclosed terms.
A mutual cost-bearing order in a stipulated Federal Circuit dismissal typically indicates a negotiated exit rather than a concession by one party. It suggests neither Apple nor AliveCor extracted sufficient value from the litigation to justify pursuing a cost award. This structure is consistent with a parallel commercial resolution — such as a licensing or coexistence agreement — though the public record does not confirm this.
Whether Apple is barred from future challenges depends on whether the dismissal was with or without prejudice — a distinction the public docket does not specify. If the parties’ private agreement included a with-prejudice term, Apple’s ability to re-challenge the same claims would be restricted. Without that information, practitioners should not assume either outcome. A review of any underlying settlement agreement, if obtainable, would be required.
PatSnap Eureka searches patents and litigation data to answer instantly.